WEATHERMAN ELIZABETH H 4

What Happened
Elizabeth H. Weatherman, a director of Royalty Pharma plc (RPRX), was granted 4,545 restricted stock units (reported as 4,545 shares acquired) on June 5, 2026. The grant is reported at $0.00 per share (an equity award, not a cash purchase), so no cash was paid on grant. This is a compensation award under the company's director equity plan rather than an open‑market buy or sale.

Key Details

• Transaction date: 2026-06-05; Form 4 filed: 2026-06-08 (Accession 0001188681-26-000003).
• Transaction type/code: Award/Grant (Code A).
• Quantity and price: 4,545 RSUs @ $0.00 (no cash consideration at grant).
• Shares owned after transaction: not specified in the provided filing details.
• Vesting: per footnote, the RSUs generally vest 100% on the earlier of (i) one year after the grant date or (ii) the date of the issuer's annual meeting in the first calendar year following the grant, subject to the plan and award agreement.
• No 10b5-1, tax‑withholding, or immediate sale noted in the reported transaction.

Context
RSUs are a form of compensation that convert into shares only after vesting; they do not represent immediate cash proceeds or market purchases/sales. Such director grants are routine corporate compensation and should be viewed differently from open‑market purchases (which can signal insider confidence) or sales (which can signal liquidity needs or portfolio changes).